Imaging Biomarkers Market: An Overview
The imaging biomarkers market is expected to witness robust growth during 2018-2028 periods. The imaging biomarkers market is a consolidated and competitive landscape, with key players in the market making way advanced imaging techniques for detection of chronic diseases like cancer. The high-tech know-how of manufacturing remains a potential barrier to entry in the market. However, due to the complex and potent nature of the technique, research and development continues to make way for new opportunities for key players in the market are Abbott Laboratories, Agilent Technologies Inc., Affymetrix Inc., Bio-Rad Laboratories Inc., F. Hoffmann La Roche Ltd., Gen-Probe Inc., and Siemens Healthcare. The strong rivalry in the market dictates strong opportunities for new entrants in supply of imaging biomarkers. The cost-effective, localized, and highly complex nature of the product provides a high-degree of power to suppliers which is expected to help the market expand in new regions.
Imaging Biomarkers Market: Notable Developments
The European Society of Radiology (ESR) has issued a 16 page document outlining a detailed set of instructions to promote the use of imaging biomarkers in clinical trials. The instructions are expected to further understanding of imaging biomarkers, and usage of validated imaging biomarkers. The insight was published in Insights Into Imaging. According to its author, Nandita D’Souza, the imaging biomarkers often come with different protocols, which make the quantitation and subsequent usage of equipment more challenging.
The brain imaging study conducted by researchers from University of California show that tau pathology rather than than β-amyloid plaque formation may be key to progress of Alzheimer’s disease. The study published in Science Transnational Medicine, promises the use of PET tracer in quantifying, and visualizing pathological tau protein tangles. The study also promises more potential for imaging biomarkers as these could potentially be used to study progression of the Alzheimer’s disease.
Imaging Biomarkers Market: Drivers and Restraints
The imaging biomarkers market remains a promising prospect for new entrants, thanks to rising innovation. The growing cases of chronic diseases like cancer including lung, liver, and stomach cancer have resulted in increased deaths. On the other hand, the healthcare sector is moving towards identification of cancer earlier to provide the best treatment possible. The growing awareness of the disease, the increased screening, and awareness among patients, and increased product advancements are expected to drive growth of the imaging biomarkers market.
Additionally, increased technological advancements like virtualization of imaging biomarkers, and technologies like Big Data are making way for highly complex imaging techniques. This is expected to open up new opportunities as various scans including PET imaging, MRI, and CT scans provide various insights into chronic illnesses like cancer. Moreover, the growth of these technologies are expected to drive growth for the imaging biomarkers market in near future.
Imaging Biomarkers Market: Geographical Analysis
Imaging biomarkers market report covers all regions of the globe including North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Among these, the North America region is expected to witness highest revenue growth with growing elderly population, rising coverage through favourable disbursement scenario, and growing cases of cancer detection. The Asia Pacific region is expected to also present significant opportunities as expanding access to healthcare, large population, and rising disposable income are expected to drive highest CAGR-drive growth in the region for the imaging biomarkers market.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.